InvestorsHub Logo
Followers 23
Posts 3336
Boards Moderated 0
Alias Born 08/05/2019

Re: None

Tuesday, 10/20/2020 3:33:04 PM

Tuesday, October 20, 2020 3:33:04 PM

Post# of 191
September 25, 2020 Cardiol Therapeutics Receives FDA Approval for Investigational New Drug (IND) Application for Phase II/III COVID-19 Trial

Trial will take place at major U.S. centers and examine the cardioprotective properties of CardiolRx™ in patients hospitalized with COVID-19 who have a prior history of, or risk factors for, cardiovascular disease (CVD)

https://www.cardiolrx.com/cardiol-therapeutics-receives-fda-approval-for-investigational-new-drug-ind-application-for-phase-ii-iii-covid-19-trial/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRDL News